Intervention
DXA scan
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownNormal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or TirzepatideNCT06657209 · 2025-01-13
RECRUITINGMEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes MellitusNCT03945747 · 2019-08-14
ACTIVE_NOT_RECRUITINGPrevalence of Vertebral Fractures in Patients With Type 1 DiabetesNCT04064437 · 2019-07-29
COMPLETEDStudy of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's DiseaseNCT02930512 · 2016-06-21
UNKNOWNMetabolic Complications Following Knee Injury in Young and Middle Aged PatientsNCT02573662 · 2015-04-01
UNKNOWNCommon conditions
Diabetes Mellitus, Type 12Autoimmune Diabetes1Bone Fracture1Bone Health1Diabetes1Diabetes Mellitus Complication1Diabetes Mellitus, Type 21Diabetic Kidney Disease1Diabetic Nephropathies1Glucose Metabolism Disorders1Juvenile Diabetes1Lipid Metabolism Disorders1Metabolic Disease1Parkinson's Disease1Pre Diabetes1Sedentary Lifestyle1Type 2 Diabetes1Type1 Diabetes Mellitus1
Leading sponsors
Trial status mix
UNKNOWN2
ACTIVE_NOT_RECRUITING1
COMPLETED1
RECRUITING1
Phase mix
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.